Drs. Murdock and Shlomov explain how to recognize the common signs of thyroid eye disease and discuss a patient who was successfully treated with teprotumumab.
TED MicroModules: A Case of Asymmetric and Quiet TED
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
TED MicroModules: A Case of Asymmetric and Quiet TED
Restart
Resume
Share this program on:
Choose a format
Take Post-TestSkip straight to the post-test if you have already participated in this activity
Media formats available:
0.25 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
Overview
Disclosure of Conflicts of Interest
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Jennifer Murdock, MD, (Chair) has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alastin Skincare, Galderma Laboratories, and Horizon Therapeutics. Speaker's Bureau: Horizon Therapeutics.
Rachel Shlomov, OD, has no financial relationships or affiliations with ineligible companies.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Conduct a comprehensive clinical assessment that characterizes orbital, ocular surface, and optic nerve involvement; inflammatory activity; and disease severity to aid in the diagnosis of thyroid eye disease
- Differentiate between thyroid eye disease and conditions that have significant overlap in clinical manifestations
- Summarize the treatment options available for patients with varying levels of thyroid eye disease activity and severity
- Prepare timely referrals of patients presenting with the signs and symptoms of thyroid eye disease to relevant health care specialists
Target Audience
This certified continuing education activity is designed for comprehensive ophthalmologists, optometrists, primary care physicians, and endocrinology advanced practice providers.
Accreditation and Credit Designation Statements
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Provider(s)/Educational Partner(s)
Evolve Medical Education LLC (Evolve) is a leader in cultivating health care for patients by educating clinical competence of the health care team. Evolve achieves this by developing and distributing high-quality, evidence-based, valid, independent CME/CE activities in a variety of learning formats. These activities are designed to increase clinician’s knowledge, skills, competence and professional performance as well as to promote professional growth, maintenance of licensure, and support quality change in care of patients.Commercial Support
This activity is supported by an unrestricted educational grant from Horizon Therapeutics.
Disclaimer
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Horizon Therapeutics.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
System Requirements
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.
Publication Dates
Release Date:
Expiration Date:
Presenters
Related
videoTED MicroModules: An Unusual Case of Inflammatory TED
Show more
Recommended
Details
Presenters
Related
Comments
Recommended
Overview
Drs. Murdock and Shlomov explain how to recognize the common signs of thyroid eye disease and discuss a patient who was successfully treated with teprotumumab.
Disclosure of Conflicts of Interest
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Jennifer Murdock, MD, (Chair) has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alastin Skincare, Galderma Laboratories, and Horizon Therapeutics. Speaker's Bureau: Horizon Therapeutics.
Rachel Shlomov, OD, has no financial relationships or affiliations with ineligible companies.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Conduct a comprehensive clinical assessment that characterizes orbital, ocular surface, and optic nerve involvement; inflammatory activity; and disease severity to aid in the diagnosis of thyroid eye disease
- Differentiate between thyroid eye disease and conditions that have significant overlap in clinical manifestations
- Summarize the treatment options available for patients with varying levels of thyroid eye disease activity and severity
- Prepare timely referrals of patients presenting with the signs and symptoms of thyroid eye disease to relevant health care specialists
Target Audience
This certified continuing education activity is designed for comprehensive ophthalmologists, optometrists, primary care physicians, and endocrinology advanced practice providers.
Accreditation and Credit Designation Statements
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Provider(s)/Educational Partner(s)
Evolve Medical Education LLC (Evolve) is a leader in cultivating health care for patients by educating clinical competence of the health care team. Evolve achieves this by developing and distributing high-quality, evidence-based, valid, independent CME/CE activities in a variety of learning formats. These activities are designed to increase clinician’s knowledge, skills, competence and professional performance as well as to promote professional growth, maintenance of licensure, and support quality change in care of patients.Commercial Support
This activity is supported by an unrestricted educational grant from Horizon Therapeutics.
Disclaimer
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Horizon Therapeutics.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
System Requirements
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.
Publication Dates
Release Date:
Expiration Date:
Presenters
Related
- video
TED MicroModules: An Unusual Case of Inflammatory TED
Show more
Facebook Comments